BioSpace News Archive

Vision Research, a leading manufacturer of digital high-speed imaging systems, has for the first time supplied an embedded Phantom high-speed camera for use within a medical device with U.S. Food and Drug Administration (FDA) 501(k) clearance.

Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development

Valbiotis announces positive results in the bioavailability and mode of action clinical study conducted on TOTUM•854 against high blood pressure, the number one cardiovascular risk factor worldwide.

Aeolian Biotech Corp. today announced the formation and launch of the Company to focus on the development of an improved pneumococcal conjugate vaccine, ‘iPCV22’, to address the threat of circulating and emerging pneumococcal serotypes.

Verisense Health will provide pharmaceutical companies with access to a cost-effective digital health data collection platform, study management expertise, and a digital biobank of raw patient data.

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the statewide practice.

Matinas BioPharma (NYSE AMER: MTNB, Matinas), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, today is providing a business update on its ongoing programs and discussing its strategic outlook for 2023.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Christine Silverstein to its Board of Directors and Audit Committee.

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce its Trademark, Your Fountain of Youth, was granted protection in Switzerland by its Trademark Office.

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to announce that the Company has granted stock options (“Options”) to employees, officers and directors of the Company.